Valo Health and Novo Nordisk collaborate to discover novel treatments for cardiometabolic diseases using human data and AI.
Bagsværd, Denmark and Boston, Massachusetts, US, 25 September 2023 – Novo Nordisk A/S and Valo Health, Inc. today announced they have entered into an agreement to discover and develop novel treatments for cardiometabolic diseases based on Valo’s large human dataset and computation…